• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺疾病的凝血异常谱。

The spectrum of coagulation abnormalities in thyroid disorders.

机构信息

Divisione di Medicina, Ospedale Carlo Poma, Mantova, Italy.

出版信息

Semin Thromb Hemost. 2011 Feb;37(1):7-10. doi: 10.1055/s-0030-1270065. Epub 2011 Jan 19.

DOI:10.1055/s-0030-1270065
PMID:21249600
Abstract

The hemostatic balance is a complex system where the delicate equilibrium is regulated by several factors including hormones. A variety of endocrine disorders have been reported to be associated with coagulation abnormalities, ranging from mild laboratory changes to clinically relevant thrombotic or bleeding manifestations. In this review, we summarize the current knowledge on the main abnormalities of the coagulation and fibrinolytic systems associated with thyroid dysfunctions. Overall, although mostly based on uncontrolled studies, data in the literature suggest that patients with hyperthyroidism or subclinical hypothyroidism have a hypercoagulative state, whereas patients with overt hypothyroidism have a bleeding tendency.

摘要

止血平衡是一个复杂的系统,其微妙的平衡由多种因素调节,包括激素。据报道,多种内分泌紊乱与凝血异常有关,从轻微的实验室改变到具有临床相关性的血栓形成或出血表现。在这篇综述中,我们总结了与甲状腺功能障碍相关的凝血和纤维蛋白溶解系统主要异常的现有知识。总的来说,尽管主要基于非对照研究,但文献中的数据表明,甲状腺功能亢进症或亚临床甲状腺功能减退症患者存在高凝状态,而显性甲状腺功能减退症患者则有出血倾向。

相似文献

1
The spectrum of coagulation abnormalities in thyroid disorders.甲状腺疾病的凝血异常谱。
Semin Thromb Hemost. 2011 Feb;37(1):7-10. doi: 10.1055/s-0030-1270065. Epub 2011 Jan 19.
2
Thyroid disorders and hypercoagulability.甲状腺疾病与高凝状态。
Semin Thromb Hemost. 2011 Feb;37(1):17-26. doi: 10.1055/s-0030-1270067. Epub 2011 Jan 19.
3
Thyroid dysfunction and hemostasis: an issue still unresolved.甲状腺功能障碍与止血:一个仍未解决的问题。
Semin Thromb Hemost. 2009 Apr;35(3):288-94. doi: 10.1055/s-0029-1222607. Epub 2009 May 18.
4
Hemostatic changes in thyroid diseases: haemostasis and thrombosis.甲状腺疾病中的止血变化:止血与血栓形成
Hematology. 2006 Jun;11(3):203-8. doi: 10.1080/10245330600667591.
5
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.
6
[Thyroid and hemostasis].[甲状腺与止血]
Recenti Prog Med. 2006 May;97(5):267-71.
7
Hemostatic abnormalities in endocrine and metabolic disorders.内分泌和代谢紊乱中的止血异常。
Eur J Endocrinol. 2010 Mar;162(3):439-51. doi: 10.1530/EJE-09-0958. Epub 2009 Nov 24.
8
Coagulation and fibrinolysis in thyroid dysfunction.甲状腺功能障碍中的凝血与纤维蛋白溶解
Endocrine. 2009 Aug;36(1):110-8. doi: 10.1007/s12020-009-9185-z. Epub 2009 Apr 15.
9
Thyroid disorders and hypocoagulability.甲状腺疾病与低凝状态。
Semin Thromb Hemost. 2011 Feb;37(1):11-6. doi: 10.1055/s-0030-1270066.
10
Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review.内分泌疾病中的止血和纤溶异常:叙述性综述。
Semin Thromb Hemost. 2009 Oct;35(7):605-12. doi: 10.1055/s-0029-1242714.

引用本文的文献

1
The Influence of Hyperthyroid Metabolic Status on the Coagulation and Fibrinolysis System and the Risk of Thrombosis: A Prospective Cohort Study.甲状腺功能亢进代谢状态对凝血和纤溶系统的影响及血栓形成风险:一项前瞻性队列研究。
Biomedicines. 2025 Aug 1;13(8):1869. doi: 10.3390/biomedicines13081869.
2
Delayed hemothorax readmissions after rib fracture in blunt trauma patients.钝性创伤患者肋骨骨折后迟发性血胸再入院情况。
J Clin Orthop Trauma. 2023 Oct 14;45:102259. doi: 10.1016/j.jcot.2023.102259. eCollection 2023 Oct.
3
Menorrhagia as main presentation sign of severe hypothyroidism in a pediatric patient: a case report.
以月经过多为主要表现的儿童重度甲状腺功能减退症 1 例报告
Ital J Pediatr. 2022 Sep 11;48(1):171. doi: 10.1186/s13052-022-01363-x.
4
Preconception Counseling in Patients with Hypothyroidism and/or Thyroid Autoimmunity.甲状腺功能减退症和/或甲状腺自身免疫患者的孕前咨询。
Medicina (Kaunas). 2022 Aug 18;58(8):1122. doi: 10.3390/medicina58081122.
5
Hemostasis in Overt and Subclinical Hyperthyroidism.显性和亚临床甲状腺功能亢进症中的止血作用。
Int J Endocrinol Metab. 2017 Apr 23;15(3):e44157. doi: 10.5812/ijem.44157. eCollection 2017 Jul.
6
Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.甲状腺功能减退症和自身免疫性甲状腺疾病中的止血作用。
Int J Endocrinol Metab. 2017 Mar 9;15(2):e42649. doi: 10.5812/ijem.42649. eCollection 2017 Apr.
7
Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy.甲状腺肿瘤的蛋白质组学为其分子组成及与恶性肿瘤相关的变化提供了新的见解。
Sci Rep. 2016 Mar 30;6:23660. doi: 10.1038/srep23660.
8
Hyperthyroidism: A rare cause of pulmonary embolism: Report of two cases.甲状腺功能亢进症:肺栓塞的罕见病因:两例报告
Indian J Endocrinol Metab. 2013 Nov;17(6):1104-7. doi: 10.4103/2230-8210.122640.
9
A review of the evidence for and against increased mortality in hypothyroidism.甲状腺功能减退症患者死亡率增加的证据综述。
Nat Rev Endocrinol. 2012 Mar 6;8(7):417-24. doi: 10.1038/nrendo.2012.29.